Լիթիում (դեղորայք) (Armenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Լիթիում (դեղորայք)" in Armenian language version.

refsWebsite

Global rank Armenian rank

108nih.gov

4^th place

3^rd place

81doi.org

2^nd place

4^th place

33semanticscholar.org

11^th place

428^th place

28web.archive.org

1^st place

10archive.org

6^th place

5books.google.com

3^rd place

17^th place

5handle.net

102^nd place

2,318^th place

4worldcat.org

5^th place

10^th place

3drugs.com

399^th place

102^nd place

3who.int

195^th place

49^th place

2clincalc.com

3,912^th place

1,857^th place

2uptodate.com

3,771^st place

983^rd place

2harvard.edu

18^th place

38^th place

1aafp.org

1,916^th place

203^rd place

1fda.gov

447^th place

244^th place

1archive.today

14^th place

48^th place

1loc.gov

70^th place

118^th place

1ajgponline.org

low place

1sagepub.com

731^st place

880^th place

1medscape.com

719^th place

149^th place

1tga.gov.au

3,984^th place

1,282^nd place

1npsa.nhs.uk

low place

1evidence.nhs.uk

low place

1webmd.com

1,169^th place

367^th place

1inhn.org

low place

1anu.edu.au

942^nd place

1,671^st place

1snopes.com

944^th place

3,260^th place

1news.google.com

59^th place

533^rd place

1nhs.uk

1,989^th place

322^nd place

aafp.org

Armstrong C (15 September 2008). «ACOG Guidelines on Psychiatric Medication Use During Pregnancy and Lactation». American Family Physician. 78 (6): 772. ISSN 0002-838X. Արխիվացված օրիգինալից 27 January 2022-ին. Վերցված է 27 January 2022-ին.

ajgponline.org

Almeida OP, Etherton-Beer C, Kelty E, Sanfilippo F, Preen DB, Page A (27 March 2023). «Lithium dispensed for adults aged ≥ 50 years between 2012 and 2021: Analyses of a 10% sample of the Australian Pharmaceutical Benefits Scheme». The American Journal of Geriatric Psychiatry (English). 31 (9): 716–725. doi:10.1016/j.jagp.2023.03.012. ISSN 1064-7481. PMID 37080815. S2CID 257824414. Արխիվացված օրիգինալից 31 March 2023-ին. Վերցված է 31 March 2023-ին.{{cite journal}}: CS1 սպաս․ չճանաչված լեզու (link)

anu.edu.au

oa.anu.edu.au

«Obituary – Shirley Aldythea Andrews – Obituaries Australia». oa.anu.edu.au. Արխիվացված օրիգինալից 26 October 2022-ին. Վերցված է 26 October 2022-ին.

archive.org

Lenox RH, Watson DG (February 1994). «Lithium and the brain: a psychopharmacological strategy to a molecular basis for manic depressive illness». Clinical Chemistry. 40 (2): 309–314. doi:10.1093/clinchem/40.2.309. PMID 8313612.
Hampel H, Ewers M, Bürger K, Annas P, Mörtberg A, Bogstedt A, Frölich L, Schröder J, Schönknecht P, Riepe MW, Kraft I, Gasser T, Leyhe T, Möller HJ, Kurz A, Basun H (June 2009). «Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study». The Journal of Clinical Psychiatry. 70 (6): 922–931. doi:10.4088/JCP.08m04606. PMID 19573486.
Baselt R (2008). Disposition of Toxic Drugs and Chemicals in Man (8th ed.). Foster City, CA: Biomedical Publications. էջեր 851–854. ISBN 978-0-9626523-7-0.
Joint Formulary Committee (2013). British National Formulary (BNF) 65. London, UK: Pharmaceutical Press. էջեր 240–242. ISBN 978-0-85711-084-8.
Wetzels JF, van Bergeijk JD, Hoitsma AJ, Huysmans FT, Koene RA (1989). «Triamterene increases lithium excretion in healthy subjects: evidence for lithium transport in the cortical collecting tubule». Nephrology, Dialysis, Transplantation. 4 (11): 939–942. doi:10.1093/ndt/4.11.939. PMID 2516883.
Bendz H, Schön S, Attman PO, Aurell M (February 2010). «Renal failure occurs in chronic lithium treatment but is uncommon». Kidney International. 77 (3): 219–224. doi:10.1038/ki.2009.433. PMID 19940841.
Alexander MP, Farag YM, Mittal BV, Rennke HG, Singh AK (January 2008). «Lithium toxicity: a double-edged sword». Kidney International. 73 (2): 233–237. doi:10.1038/sj.ki.5002578. PMID 17943083.
Garofeanu CG, Weir M, Rosas-Arellano MP, Henson G, Garg AX, Clark WF (April 2005). «Causes of reversible nephrogenic diabetes insipidus: a systematic review». American Journal of Kidney Diseases. 45 (4): 626–637. doi:10.1053/j.ajkd.2005.01.008. PMID 15806465.
Presne C, Fakhouri F, Noël LH, Stengel B, Even C, Kreis H, Mignon F, Grünfeld JP (August 2003). «Lithium-induced nephropathy: Rate of progression and prognostic factors». Kidney International. 64 (2): 585–592. doi:10.1046/j.1523-1755.2003.00096.x. PMID 12846754.
Einat H, Manji HK (June 2006). «Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder». Biological Psychiatry. 59 (12): 1160–1171. doi:10.1016/j.biopsych.2005.11.004. PMID 16457783. S2CID 20669215.

archive.today

«Lithium Carbonate Medication Guide» (PDF). U.S. FDA. Արխիվացված (PDF) օրիգինալից 27 January 2022-ին. Վերցված է 27 January 2022-ին.

books.google.com

Sneader W (2005). Drug discovery : a history (Rev. and updated ed.). Chichester: Wiley. էջ 63. ISBN 978-0-471-89979-2. Արխիվացված օրիգինալից 8 September 2017-ին.
Fieve RR (1984). «Lithium: its clinical uses and biological mechanisms of action». In Habig RL (ed.). The Brain, Biochemistry, and Behavior: Proceedings of the Sixth Arnold O. Beckman Conference in Clinical Chemistry (անգլերեն). American Association for Clinical Chemistry. էջ 170. ISBN 978-0-915274-22-2. Արխիվացված օրիգինալից 26 February 2024-ին. Վերցված է 27 May 2022-ին.
Bauer M, Grof P, Muller-Oerlinghausen B (2006). Lithium in Neuropsychiatry: The Comprehensive Guide. Taylor & Francis. ISBN 978-1-84184-515-9. Արխիվացված օրիգինալից 26 February 2024-ին. Վերցված է 17 July 2021-ին.
Keshavan MS, Kennedy JS (2001). Drug-induced dysfunction in psychiatry. Taylor & Francis. էջ 305. ISBN 978-0-89116-961-1.
Birch NJ (2 December 2012). Lithium and the Cell: Pharmacology and Biochemistry. Academic Press. ISBN 978-0-08-098429-2. Արխիվացված օրիգինալից 26 February 2024-ին. Վերցված է 9 October 2020-ին.

clincalc.com

«The Top 300 of 2020». ClinCalc. Արխիվացված օրիգինալից 26 March 2023-ին. Վերցված է 7 October 2022-ին.
«Lithium – Drug Usage Statistics». ClinCalc. Արխիվացված օրիգինալից 10 June 2023-ին. Վերցված է 7 October 2022-ին.

doi.org

Poels EM, Bijma HH, Galbally M, Bergink V (December 2018). «Lithium during pregnancy and after delivery: a review». International Journal of Bipolar Disorders. 6 (1): 26. doi:10.1186/s40345-018-0135-7. PMC 6274637. PMID 30506447.
Lenox RH, Watson DG (February 1994). «Lithium and the brain: a psychopharmacological strategy to a molecular basis for manic depressive illness». Clinical Chemistry. 40 (2): 309–314. doi:10.1093/clinchem/40.2.309. PMID 8313612.
Almeida OP, Etherton-Beer C, Kelty E, Sanfilippo F, Preen DB, Page A (27 March 2023). «Lithium dispensed for adults aged ≥ 50 years between 2012 and 2021: Analyses of a 10% sample of the Australian Pharmaceutical Benefits Scheme». The American Journal of Geriatric Psychiatry (English). 31 (9): 716–725. doi:10.1016/j.jagp.2023.03.012. ISSN 1064-7481. PMID 37080815. S2CID 257824414. Արխիվացված օրիգինալից 31 March 2023-ին. Վերցված է 31 March 2023-ին.{{cite journal}}: CS1 սպաս․ չճանաչված լեզու (link)
Bauer M, Adli M, Ricken R, Severus E, Pilhatsch M (April 2014). «Role of lithium augmentation in the management of major depressive disorder». CNS Drugs. 28 (4): 331–342. doi:10.1007/s40263-014-0152-8. PMID 24590663. S2CID 256840.
Shorter E (June 2009). «The history of lithium therapy». Bipolar Disorders. 11 (Suppl 2): 4–9. doi:10.1111/j.1399-5618.2009.00706.x. PMC 3712976. PMID 19538681.
McKnight RF, de La Motte de Broöns de Vauvert SJ, Chesney E, Amit BH, Geddes J, Cipriani A (June 2019). «Lithium for acute mania». The Cochrane Database of Systematic Reviews. 2019 (6): CD004048. doi:10.1002/14651858.CD004048.pub4. PMC 6544558. PMID 31152444.
Rakofsky JJ, Lucido MJ, Dunlop BW (July 2022). «Lithium in the treatment of acute bipolar depression: A systematic review and meta-analysis». Journal of Affective Disorders. 308: 268–280. doi:10.1016/j.jad.2022.04.058. PMID 35429528. S2CID 248161621.
Riedinger MA, van der Wee NJ, Giltay EJ, de Leeuw M (September 2023). «Lithium in bipolar depression: A review of the evidence». Human Psychopharmacology. 38 (5): e2881. doi:10.1002/hup.2881. hdl:10067/2003410151162165141. PMID 37789577.
Cai L, Chen G, Yang H, Bai Y (July 2023). «Efficacy and safety profiles of mood stabilizers and antipsychotics for bipolar depression: a systematic review». International Clinical Psychopharmacology. 38 (4): 249–260. doi:10.1097/YIC.0000000000000449. PMID 36947416. S2CID 257665886.
Hsu CW, Tsai SY, Tseng PT, Liang CS, Vieta E, Carvalho AF, Stubbs B, Kao HY, Tu YK, Lin PY (May 2022). «Differences in the prophylactic effect of serum lithium levels on depression and mania in bipolar disorder: A dose-response meta-analysis». European Neuropsychopharmacology. 58: 20–29. doi:10.1016/j.euroneuro.2022.01.112. PMID 35158229. S2CID 246754349.
Rosenberg JM, Salzman C (November 2007). «Update: new uses for lithium and anticonvulsants». CNS Spectrums. 12 (11): 831–841. doi:10.1017/S1092852900015571. PMID 17984856. S2CID 26227696.
Frye MA, Salloum IM (December 2006). «Bipolar disorder and comorbid alcoholism: prevalence rate and treatment considerations». Bipolar Disorders. 8 (6): 677–685. doi:10.1111/j.1399-5618.2006.00370.x. PMID 17156154.
Nabi Z, Stansfeld J, Plöderl M, Wood L, Moncrieff J (September 2022). «Effects of lithium on suicide and suicidal behaviour: a systematic review and meta-analysis of randomised trials». Epidemiology and Psychiatric Sciences. 31: e65. doi:10.1017/S204579602200049X. PMC 9533115. PMID 36111461.
Undurraga J, Sim K, Tondo L, Gorodischer A, Azua E, Tay KH, Tan D, Baldessarini RJ (February 2019). «Lithium treatment for unipolar major depressive disorder: Systematic review». Journal of Psychopharmacology. 33 (2): 167–176. doi:10.1177/0269881118822161. PMID 30698058. S2CID 59411183. Արխիվացված օրիգինալից 20 February 2024-ին. Վերցված է 20 February 2024-ին.
Bauer M, Gitlin M (2016). «Treatment of Depression with Lithium». The Essential Guide to Lithium Treatment. Cham: Springer International Publishing. էջեր 71–80. doi:10.1007/978-3-319-31214-9_7. ISBN 978-3-319-31212-5.
Nabi Z, Stansfeld J, Plöderl M, Wood L, Moncrieff J (September 2022). «Effects of lithium on suicide and suicidal behaviour: a systematic review and meta-analysis of randomised trials». Epidemiology and Psychiatric Sciences. 31: e65. doi:10.1017/S204579602200049X. PMC 9533115. PMID 36111461.
Del Matto L, Muscas M, Murru A, Verdolini N, Anmella G, Fico G, Corponi F, Carvalho AF, Samalin L, Carpiniello B, Fagiolini A, Vieta E, Pacchiarotti I (September 2020). «Lithium and suicide prevention in mood disorders and in the general population: A systematic review». Neuroscience and Biobehavioral Reviews. 116: 142–153. doi:10.1016/j.neubiorev.2020.06.017. PMID 32561344. S2CID 219942979.
Börjesson J, Gøtzsche PC (September 2019). «Effect of lithium on suicide and mortality in mood disorders: a systematic review». The International Journal of Risk & Safety in Medicine. 30 (3): 155–166. doi:10.3233/JRS-190058. PMID 31381531. S2CID 199451710.
Riblet NV, Shiner B, Young-Xu Y, Watts BV (November 2022). «Lithium in the prevention of suicide in adults: systematic review and meta-analysis of clinical trials». BJPsych Open. 8 (6): e199. doi:10.1192/bjo.2022.605. PMC 9707499. PMID 36384820.
Cipriani A, Hawton K, Stockton S, Geddes JR (June 2013). «Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis». BMJ. 346: f3646. doi:10.1136/bmj.f3646. PMID 23814104.
Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J (October 2006). «Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review». Bipolar Disorders. 8 (5p2): 625–639. doi:10.1111/j.1399-5618.2006.00344.x. PMID 17042835.
Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, Cummings J, van der Flier WM (April 2021). «Alzheimer's disease». Lancet. 397 (10284): 1577–1590. doi:10.1016/S0140-6736(20)32205-4. PMC 8354300. PMID 33667416.
Haussmann R, Noppes F, Brandt MD, Bauer M, Donix M (August 2021). «Lithium: A therapeutic option in Alzheimer's disease and its prodromal stages?». Neuroscience Letters. 760: 136044. doi:10.1016/j.neulet.2021.136044. PMID 34119602. S2CID 235385875.
Wei HF, Anchipolovsky S, Vera R, Liang G, Chuang DM (March 2022). «Potential mechanisms underlying lithium treatment for Alzheimer's disease and COVID-19». European Review for Medical and Pharmacological Sciences. 26 (6): 2201–2214. doi:10.26355/eurrev_202203_28369. PMC 9173589. PMID 35363371.
Hampel H, Ewers M, Bürger K, Annas P, Mörtberg A, Bogstedt A, Frölich L, Schröder J, Schönknecht P, Riepe MW, Kraft I, Gasser T, Leyhe T, Möller HJ, Kurz A, Basun H (June 2009). «Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study». The Journal of Clinical Psychiatry. 70 (6): 922–931. doi:10.4088/JCP.08m04606. PMID 19573486.
Kessing LV, Gerds TA, Knudsen NN, Jørgensen LF, Kristiansen SM, Voutchkova D, Ernstsen V, Schullehner J, Hansen B, Andersen PK, Ersbøll AK (October 2017). «Association of Lithium in Drinking Water With the Incidence of Dementia». JAMA Psychiatry. 74 (10): 1005–1010. doi:10.1001/jamapsychiatry.2017.2362. PMC 5710473. PMID 28832877.
Amdisen A (1978). «Clinical and serum level monitoring in lithium therapy and lithium intoxication». Journal of Analytical Toxicology. 2 (5): 193–202. doi:10.1093/jat/2.5.193.
Grandjean EM, Aubry JM (2009). «Lithium: updated human knowledge using an evidence-based approach. Part II: Clinical pharmacology and therapeutic monitoring». CNS Drugs. Springer Science and Business Media LLC. 23 (4): 331–349. doi:10.2165/00023210-200923040-00005. PMID 19374461. S2CID 38042857.
Gitlin M (December 2016). «Lithium side effects and toxicity: prevalence and management strategies». International Journal of Bipolar Disorders. 4 (1): 27. doi:10.1186/s40345-016-0068-y. PMC 5164879. PMID 27900734.
Davis J, Desmond M, Berk M (November 2018). «Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification». BMC Nephrology. Springer Science and Business Media LLC. 19 (1): 305. doi:10.1186/s12882-018-1101-4. PMC 6215627. PMID 30390660.
Yazici O, Kora K, Polat A, Saylan M (June 2004). «Controlled lithium discontinuation in bipolar patients with good response to long-term lithium prophylaxis». Journal of Affective Disorders. 80 (2–3): 269–271. doi:10.1016/S0165-0327(03)00133-2. PMID 15207941.
Gutwinski S, Fierley L, Schreiter S, Bermpohl F, Heinz A, Henssler J (October 2021). «[Lithium Withdrawal Symptoms – A Systematic Review]». Psychiatrische Praxis (գերմաներեն). Georg Thieme Verlag KG. 48 (7): 341–350. doi:10.1055/a-1481-1953. PMID 34015856. S2CID 243025798.
Aiff H, Attman PO, Aurell M, Bendz H, Ramsauer B, Schön S, Svedlund J (May 2015). «Effects of 10 to 30 years of lithium treatment on kidney function». Journal of Psychopharmacology. 29 (5): 608–614. doi:10.1177/0269881115573808. PMID 25735990. S2CID 9496408.
Baek JH, Kinrys G, Nierenberg AA (January 2014). «Lithium tremor revisited: pathophysiology and treatment». Acta Psychiatrica Scandinavica. Wiley. 129 (1): 17–23. doi:10.1111/acps.12171. PMID 23834617. S2CID 33784257.
Strawbridge R, Young AH (January 2024). «Lithium: how low can you go?». International Journal of Bipolar Disorders. 12 (1): 4. doi:10.1186/s40345-024-00325-y. PMC 10828288. PMID 38289425. «An in-depth recent study reported high interindividual variation but steeper declines in estimated glomerular filtration rate (eGFR) explained by lithium use but also found wrongful clinical attribution of some chronic kidney disease (CKD) cases to lithium (Fransson et al. 2022) which may have increased other records-based studies' estimates (Strawbridge and Young 2022). [...]»
Kessing LV (January 2024). «Why is lithium [not] the drug of choice for bipolar disorder? a controversy between science and clinical practice». International Journal of Bipolar Disorders. 12 (1): 3. doi:10.1186/s40345-023-00322-7. PMC 10792154. PMID 38228882.
Ben Salem C, Fathallah N, Hmouda H, Bouraoui K (January 2011). «Drug-induced hypoglycaemia: an update». Drug Safety. Springer Science and Business Media LLC. 34 (1): 21–45. doi:10.2165/11538290-000000000-00000. PMID 20942513. S2CID 33307427.
Malhi GS, Tanious M, Bargh D, Das P, Berk M (2013). «Safe and effective use of lithium». Australian Prescriber. 36: 18–21. doi:10.18773/austprescr.2013.008.
Wetzels JF, van Bergeijk JD, Hoitsma AJ, Huysmans FT, Koene RA (1989). «Triamterene increases lithium excretion in healthy subjects: evidence for lithium transport in the cortical collecting tubule». Nephrology, Dialysis, Transplantation. 4 (11): 939–942. doi:10.1093/ndt/4.11.939. PMID 2516883.
Bendz H, Schön S, Attman PO, Aurell M (February 2010). «Renal failure occurs in chronic lithium treatment but is uncommon». Kidney International. 77 (3): 219–224. doi:10.1038/ki.2009.433. PMID 19940841.
Lambert CG, Mazurie AJ, Lauve NR, Hurwitz NG, Young SS, Obenchain RL, Hengartner NW, Perkins DJ, Tohen M, Kerner B (May 2016). «Hypothyroidism risk compared among nine common bipolar disorder therapies in a large US cohort». Bipolar Disorders. 18 (3): 247–260. doi:10.1111/bdi.12391. PMC 5089566. PMID 27226264.
Shepard TH, Brent RL, Friedman JM, Jones KL, Miller RK, Moore CA, Polifka JE (April 2002). «Update on new developments in the study of human teratogens». Teratology. 65 (4): 153–161. doi:10.1002/tera.10032. PMID 11948561.
Epstein RA, Moore KM, Bobo WV (2015). «Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges». Drug, Healthcare and Patient Safety. 7: 7–29. doi:10.2147/DHPS.S50556. PMC 4284049. PMID 25565896.
Montouris G (June 2003). «Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry». Epilepsy & Behavior. 4 (3): 310–317. doi:10.1016/S1525-5050(03)00110-0. PMID 12791334. S2CID 902424.
Weinstock L, Cohen LS, Bailey JW, Blatman R, Rosenbaum JF (2001). «Obstetrical and neonatal outcome following clonazepam use during pregnancy: a case series». Psychotherapy and Psychosomatics. 70 (3): 158–162. doi:10.1159/000056242. PMID 11340418. S2CID 25166015.
Nielsen J, Kwon TH, Christensen BM, Frøkiaer J, Nielsen S (May 2008). «Dysregulation of renal aquaporins and epithelial sodium channel in lithium-induced nephrogenic diabetes insipidus». Seminars in Nephrology. 28 (3): 227–244. doi:10.1016/j.semnephrol.2008.03.002. PMID 18519084.
Alexander MP, Farag YM, Mittal BV, Rennke HG, Singh AK (January 2008). «Lithium toxicity: a double-edged sword». Kidney International. 73 (2): 233–237. doi:10.1038/sj.ki.5002578. PMID 17943083.
Sands JM, Bichet DG (February 2006). «Nephrogenic diabetes insipidus». Annals of Internal Medicine. 144 (3): 186–194. doi:10.7326/0003-4819-144-3-200602070-00007. PMID 16461963. S2CID 6732380.
Garofeanu CG, Weir M, Rosas-Arellano MP, Henson G, Garg AX, Clark WF (April 2005). «Causes of reversible nephrogenic diabetes insipidus: a systematic review». American Journal of Kidney Diseases. 45 (4): 626–637. doi:10.1053/j.ajkd.2005.01.008. PMID 15806465.
Presne C, Fakhouri F, Noël LH, Stengel B, Even C, Kreis H, Mignon F, Grünfeld JP (August 2003). «Lithium-induced nephropathy: Rate of progression and prognostic factors». Kidney International. 64 (2): 585–592. doi:10.1046/j.1523-1755.2003.00096.x. PMID 12846754.
Davis J, Desmond M, Berk M (October 2018). «Lithium and nephrotoxicity: Unravelling the complex pathophysiological threads of the lightest metal». Nephrology. Wiley. 23 (10): 897–903. doi:10.1111/nep.13263. hdl:11343/283773. PMID 29607573. S2CID 4552345.
Finley PR, O'Brien JG, Coleman RW (February 1996). «Lithium and angiotensin-converting enzyme inhibitors: evaluation of a potential interaction». Journal of Clinical Psychopharmacology. 16 (1): 68–71. doi:10.1097/00004714-199602000-00011. PMID 8834421.
Oruch R, Elderbi MA, Khattab HA, Pryme IF, Lund A (October 2014). «Lithium: a review of pharmacology, clinical uses, and toxicity». European Journal of Pharmacology. 740 (740): 464–473. doi:10.1016/j.ejphar.2014.06.042. PMID 24991789.
Netto I, Phutane VH (2012). «Reversible lithium neurotoxicity: review of the literatur». The Primary Care Companion for CNS Disorders. 14 (1): PCC.11r01197. doi:10.4088/PCC.11r01197. PMC 3357580. PMID 22690368.
Nayak SM, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR (September 2021). «Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports». Pharmacopsychiatry. 54 (5): 240–245. doi:10.1055/a-1524-2794. PMID 34348413.
Netto I, Phutane VH (2012). «Reversible lithium neurotoxicity: review of the literatur». The Primary Care Companion for CNS Disorders. 14 (1). doi:10.4088/PCC.11r01197. PMC 3357580. PMID 22690368.
Massot O, Rousselle JC, Fillion MP, Januel D, Plantefol M, Fillion G (October 1999). «5-HT1B receptors: a novel target for lithium. Possible involvement in mood disorders». Neuropsychopharmacology. 21 (4): 530–541. doi:10.1016/S0893-133X(99)00042-1. PMID 10481837.
Scheuch K, Höltje M, Budde H, Lautenschlager M, Heinz A, Ahnert-Hilger G, Priller J (January 2010). «Lithium modulates tryptophan hydroxylase 2 gene expression and serotonin release in primary cultures of serotonergic raphe neurons». Brain Research. 1307: 14–21. doi:10.1016/j.brainres.2009.10.027. PMID 19840776. S2CID 6045269.
Einat H, Manji HK (June 2006). «Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder». Biological Psychiatry. 59 (12): 1160–1171. doi:10.1016/j.biopsych.2005.11.004. PMID 16457783. S2CID 20669215.
Gould TD, Picchini AM, Einat H, Manji HK (November 2006). «Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders». Current Drug Targets. 7 (11): 1399–1409. doi:10.2174/1389450110607011399. PMID 17100580.
Böer U, Cierny I, Krause D, Heinrich A, Lin H, Mayr G, Hiemke C, Knepel W (September 2008). «Chronic lithium salt treatment reduces CRE/CREB-directed gene transcription and reverses its upregulation by chronic psychosocial stress in transgenic reporter gene mice». Neuropsychopharmacology. 33 (10): 2407–2415. doi:10.1038/sj.npp.1301640. PMID 18046304.
Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yücel M, Gama CS, Dodd S, Dean B, Magalhães PV, Amminger P, McGorry P, Malhi GS (January 2011). «Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors». Neuroscience and Biobehavioral Reviews. 35 (3): 804–817. doi:10.1016/j.neubiorev.2010.10.001. PMID 20934453. S2CID 11421586.
York JD, Ponder JW, Majerus PW (May 1995). «Definition of a metal-dependent/Li(+)-inhibited phosphomonoesterase protein family based upon a conserved three-dimensional core structure». Proceedings of the National Academy of Sciences of the United States of America. 92 (11): 5149–5153. Bibcode:1995PNAS...92.5149Y. doi:10.1073/pnas.92.11.5149. PMC 41866. PMID 7761465.
Yenush L, Bellés JM, López-Coronado JM, Gil-Mascarell R, Serrano R, Rodríguez PL (February 2000). «A novel target of lithium therapy». FEBS Letters. 467 (2–3): 321–325. Bibcode:2000FEBSL.467..321Y. doi:10.1016/s0014-5793(00)01183-2. PMID 10675562. S2CID 43250471.
Toledano E, Ogryzko V, Danchin A, Ladant D, Mechold U (April 2012). «3'-5' phosphoadenosine phosphate is an inhibitor of PARP-1 and a potential mediator of the lithium-dependent inhibition of PARP-1 in vivo». The Biochemical Journal. 443 (2): 485–490. doi:10.1042/BJ20111057. PMC 3316155. PMID 22240080.
Ghasemi M, Sadeghipour H, Mosleh A, Sadeghipour HR, Mani AR, Dehpour AR (May 2008). «Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test». European Neuropsychopharmacology. 18 (5): 323–332. doi:10.1016/j.euroneuro.2007.07.011. PMID 17728109. S2CID 44805917.
Ghasemi M, Sadeghipour H, Poorheidari G, Dehpour AR (June 2009). «A role for nitrergic system in the antidepressant-like effects of chronic lithium treatment in the mouse forced swimming test». Behavioural Brain Research. 200 (1): 76–82. doi:10.1016/j.bbr.2008.12.032. PMID 19166880. S2CID 22656735.
Ghasemi M, Raza M, Dehpour AR (April 2010). «NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test». Journal of Psychopharmacology. 24 (4): 585–594. doi:10.1177/0269881109104845. PMID 19351802. S2CID 41634565.
Malhi GS, Tanious M, Das P, Coulston CM, Berk M (February 2013). «Potential mechanisms of action of lithium in bipolar disorder. Current understanding». CNS Drugs. 27 (2): 135–153. doi:10.1007/s40263-013-0039-0. hdl:11343/218106. PMID 23371914. S2CID 26907074.
Brunello N, Tascedda F (June 2003). «Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders». The International Journal of Neuropsychopharmacology. 6 (2): 181–189. doi:10.1017/s1461145703003419. hdl:11380/305821. PMID 12890311.
Alda M (June 2015). «Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics». Molecular Psychiatry. 20 (6): 661–670. doi:10.1038/mp.2015.4. PMC 5125816. PMID 25687772.
Einat H, Kofman O, Itkin O, Lewitan RJ, Belmaker RH (1998). «Augmentation of lithium's behavioral effect by inositol uptake inhibitors». Journal of Neural Transmission. 105 (1): 31–38. doi:10.1007/s007020050035. PMID 9588758. S2CID 6707456.
Jope RS (March 1999). «Anti-bipolar therapy: mechanism of action of lithium». Molecular Psychiatry. 4 (2): 117–128. doi:10.1038/sj.mp.4000494. PMID 10208444.
Abu-Hijleh FA, Prashar S, Joshi H, Sharma R, Frey BN, Mishra RK (February 2021). «Novel mechanism of action for the mood stabilizer lithium». Bipolar Disorders. 23 (1): 76–83. doi:10.1111/bdi.13019. PMID 33037686. S2CID 222257563.
Marmol F (December 2008). «Lithium: bipolar disorder and neurodegenerative diseases Possible cellular mechanisms of the therapeutic effects of lithium». Progress in Neuro-Psychopharmacology & Biological Psychiatry. 32 (8): 1761–1771. doi:10.1016/j.pnpbp.2008.08.012. PMID 18789369. S2CID 25861243.
Cade JF (September 1949). «Lithium salts in the treatment of psychotic excitement» (PDF). The Medical Journal of Australia. 2 (10): 349–352. doi:10.1080/j.1440-1614.1999.06241.x. PMC 2560740. PMID 18142718. Արխիվացված (PDF) օրիգինալից 25 May 2006-ին.
Fieve RR (December 1999). «Lithium therapy at the millennium: a revolutionary drug used for 50 years faces competing options and possible demise». Bipolar Disorders. 1 (2): 67–70. doi:10.1034/j.1399-5618.1999.010201.x. PMID 11252660.
Wen J, Sawmiller D, Wheeldon B, Tan J (17 January 2020). «A Review for Lithium: Pharmacokinetics, Drug Design, and Toxicity». CNS & Neurological Disorders Drug Targets. 18 (10): 769–778. doi:10.2174/1871527318666191114095249. PMID 31724518. S2CID 208019043.
Forlenza OV, de Paula VJ, Machado-Vieira R, Diniz BS, Gattaz WF (May 2012). «Does lithium prevent Alzheimer's disease?». Drugs & Aging. 29 (5): 335–342. doi:10.2165/11599180-000000000-00000. PMID 22500970. S2CID 23864616.
Wilson EN, Do Carmo S, Welikovitch LA, Hall H, Aguilar LF, Foret MK, Iulita MF, Jia DT, Marks AR, Allard S, Emmerson JT, Ducatenzeiler A, Cuello AC (2020). «NP03, a Microdose Lithium Formulation, Blunts Early Amyloid Post-Plaque Neuropathology in McGill-R-Thy1-APP Alzheimer-Like Transgenic Rats». Journal of Alzheimer's Disease. 73 (2): 723–739. doi:10.3233/JAD-190862. PMID 31868669. S2CID 209448822.
Ludolph AC, Brettschneider J, Weishaupt JH (October 2012). «Amyotrophic lateral sclerosis». Current Opinion in Neurology. 25 (5): 530–535. doi:10.1097/WCO.0b013e328356d328. PMID 22918486.

drugs.com

«Lithium Salts». The American Society of Health-System Pharmacists. Արխիվացված օրիգինալից 8 December 2015-ին. Վերցված է 1 December 2015-ին.
«Lithium use while Breastfeeding». LactMed. 10 March 2015. Արխիվացված օրիգինալից 8 December 2015-ին. Վերցված է 1 December 2015-ին.
«Lithium brands». Drugs.com. Արխիվացված օրիգինալից 5 April 2017-ին. Վերցված է 4 April 2017-ին.

evidence.nhs.uk

«Lithium carbonate». Արխիվացված է օրիգինալից 25 October 2016-ին. Վերցված է 25 May 2016-ին.

fda.gov

accessdata.fda.gov

«Lithium Carbonate Medication Guide» (PDF). U.S. FDA. Արխիվացված (PDF) օրիգինալից 27 January 2022-ին. Վերցված է 27 January 2022-ին.

handle.net

hdl.handle.net

World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.
Riedinger MA, van der Wee NJ, Giltay EJ, de Leeuw M (September 2023). «Lithium in bipolar depression: A review of the evidence». Human Psychopharmacology. 38 (5): e2881. doi:10.1002/hup.2881. hdl:10067/2003410151162165141. PMID 37789577.
Davis J, Desmond M, Berk M (October 2018). «Lithium and nephrotoxicity: Unravelling the complex pathophysiological threads of the lightest metal». Nephrology. Wiley. 23 (10): 897–903. doi:10.1111/nep.13263. hdl:11343/283773. PMID 29607573. S2CID 4552345.
Malhi GS, Tanious M, Das P, Coulston CM, Berk M (February 2013). «Potential mechanisms of action of lithium in bipolar disorder. Current understanding». CNS Drugs. 27 (2): 135–153. doi:10.1007/s40263-013-0039-0. hdl:11343/218106. PMID 23371914. S2CID 26907074.
Brunello N, Tascedda F (June 2003). «Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders». The International Journal of Neuropsychopharmacology. 6 (2): 181–189. doi:10.1017/s1461145703003419. hdl:11380/305821. PMID 12890311.

harvard.edu

ui.adsabs.harvard.edu

York JD, Ponder JW, Majerus PW (May 1995). «Definition of a metal-dependent/Li(+)-inhibited phosphomonoesterase protein family based upon a conserved three-dimensional core structure». Proceedings of the National Academy of Sciences of the United States of America. 92 (11): 5149–5153. Bibcode:1995PNAS...92.5149Y. doi:10.1073/pnas.92.11.5149. PMC 41866. PMID 7761465.
Yenush L, Bellés JM, López-Coronado JM, Gil-Mascarell R, Serrano R, Rodríguez PL (February 2000). «A novel target of lithium therapy». FEBS Letters. 467 (2–3): 321–325. Bibcode:2000FEBSL.467..321Y. doi:10.1016/s0014-5793(00)01183-2. PMID 10675562. S2CID 43250471.

inhn.org

«Lithium: Discovered, Forgotten and Rediscovered». inhn.org. Արխիվացված օրիգինալից 12 March 2023-ին. Վերցված է 12 March 2023-ին.

loc.gov

webarchive.loc.gov

Mitchell PB, Hadzi-Pavlovic D (2000). «Lithium treatment for bipolar disorder» (PDF). Bulletin of the World Health Organization. 78 (4): 515–517. PMC 2560742. PMID 10885179. Արխիվացված է օրիգինալից (PDF) 1 April 2012-ին.

medscape.com

reference.medscape.com

«lithium (Rx) - Eskalith, Lithobid». Medscape. WebMD. Արխիվացված օրիգինալից 4 December 2013-ին. Վերցված է 7 October 2013-ին.

news.google.com

anonymous (13 July 1950). «ISALLY'S (ad)». Painesville Telegraph. Արխիվացված օրիգինալից 28 August 2021-ին. Վերցված է 8 September 2013-ին.

nhs.uk

«How and when to take lithium». nhs.uk (անգլերեն). 14 August 2023. Արխիվացված օրիգինալից 26 October 2023-ին. Վերցված է 6 December 2023-ին.

nih.gov

pubmed.ncbi.nlm.nih.gov

Poels EM, Bijma HH, Galbally M, Bergink V (December 2018). «Lithium during pregnancy and after delivery: a review». International Journal of Bipolar Disorders. 6 (1): 26. doi:10.1186/s40345-018-0135-7. PMC 6274637. PMID 30506447.
Lenox RH, Watson DG (February 1994). «Lithium and the brain: a psychopharmacological strategy to a molecular basis for manic depressive illness». Clinical Chemistry. 40 (2): 309–314. doi:10.1093/clinchem/40.2.309. PMID 8313612.
Mitchell PB, Hadzi-Pavlovic D (2000). «Lithium treatment for bipolar disorder» (PDF). Bulletin of the World Health Organization. 78 (4): 515–517. PMC 2560742. PMID 10885179. Արխիվացված է օրիգինալից (PDF) 1 April 2012-ին.
Almeida OP, Etherton-Beer C, Kelty E, Sanfilippo F, Preen DB, Page A (27 March 2023). «Lithium dispensed for adults aged ≥ 50 years between 2012 and 2021: Analyses of a 10% sample of the Australian Pharmaceutical Benefits Scheme». The American Journal of Geriatric Psychiatry (English). 31 (9): 716–725. doi:10.1016/j.jagp.2023.03.012. ISSN 1064-7481. PMID 37080815. S2CID 257824414. Արխիվացված օրիգինալից 31 March 2023-ին. Վերցված է 31 March 2023-ին.{{cite journal}}: CS1 սպաս․ չճանաչված լեզու (link)
Bauer M, Adli M, Ricken R, Severus E, Pilhatsch M (April 2014). «Role of lithium augmentation in the management of major depressive disorder». CNS Drugs. 28 (4): 331–342. doi:10.1007/s40263-014-0152-8. PMID 24590663. S2CID 256840.
Shorter E (June 2009). «The history of lithium therapy». Bipolar Disorders. 11 (Suppl 2): 4–9. doi:10.1111/j.1399-5618.2009.00706.x. PMC 3712976. PMID 19538681.
McKnight RF, de La Motte de Broöns de Vauvert SJ, Chesney E, Amit BH, Geddes J, Cipriani A (June 2019). «Lithium for acute mania». The Cochrane Database of Systematic Reviews. 2019 (6): CD004048. doi:10.1002/14651858.CD004048.pub4. PMC 6544558. PMID 31152444.
Rakofsky JJ, Lucido MJ, Dunlop BW (July 2022). «Lithium in the treatment of acute bipolar depression: A systematic review and meta-analysis». Journal of Affective Disorders. 308: 268–280. doi:10.1016/j.jad.2022.04.058. PMID 35429528. S2CID 248161621.
Riedinger MA, van der Wee NJ, Giltay EJ, de Leeuw M (September 2023). «Lithium in bipolar depression: A review of the evidence». Human Psychopharmacology. 38 (5): e2881. doi:10.1002/hup.2881. hdl:10067/2003410151162165141. PMID 37789577.
Cai L, Chen G, Yang H, Bai Y (July 2023). «Efficacy and safety profiles of mood stabilizers and antipsychotics for bipolar depression: a systematic review». International Clinical Psychopharmacology. 38 (4): 249–260. doi:10.1097/YIC.0000000000000449. PMID 36947416. S2CID 257665886.
Hsu CW, Tsai SY, Tseng PT, Liang CS, Vieta E, Carvalho AF, Stubbs B, Kao HY, Tu YK, Lin PY (May 2022). «Differences in the prophylactic effect of serum lithium levels on depression and mania in bipolar disorder: A dose-response meta-analysis». European Neuropsychopharmacology. 58: 20–29. doi:10.1016/j.euroneuro.2022.01.112. PMID 35158229. S2CID 246754349.
Rosenberg JM, Salzman C (November 2007). «Update: new uses for lithium and anticonvulsants». CNS Spectrums. 12 (11): 831–841. doi:10.1017/S1092852900015571. PMID 17984856. S2CID 26227696.
Frye MA, Salloum IM (December 2006). «Bipolar disorder and comorbid alcoholism: prevalence rate and treatment considerations». Bipolar Disorders. 8 (6): 677–685. doi:10.1111/j.1399-5618.2006.00370.x. PMID 17156154.
Vornik LA, Brown ES (2006). «Management of comorbid bipolar disorder and substance abuse». The Journal of Clinical Psychiatry. 67 (Suppl 7): 24–30. PMID 16961421.
Nabi Z, Stansfeld J, Plöderl M, Wood L, Moncrieff J (September 2022). «Effects of lithium on suicide and suicidal behaviour: a systematic review and meta-analysis of randomised trials». Epidemiology and Psychiatric Sciences. 31: e65. doi:10.1017/S204579602200049X. PMC 9533115. PMID 36111461.
Undurraga J, Sim K, Tondo L, Gorodischer A, Azua E, Tay KH, Tan D, Baldessarini RJ (February 2019). «Lithium treatment for unipolar major depressive disorder: Systematic review». Journal of Psychopharmacology. 33 (2): 167–176. doi:10.1177/0269881118822161. PMID 30698058. S2CID 59411183. Արխիվացված օրիգինալից 20 February 2024-ին. Վերցված է 20 February 2024-ին.
Nabi Z, Stansfeld J, Plöderl M, Wood L, Moncrieff J (September 2022). «Effects of lithium on suicide and suicidal behaviour: a systematic review and meta-analysis of randomised trials». Epidemiology and Psychiatric Sciences. 31: e65. doi:10.1017/S204579602200049X. PMC 9533115. PMID 36111461.
Del Matto L, Muscas M, Murru A, Verdolini N, Anmella G, Fico G, Corponi F, Carvalho AF, Samalin L, Carpiniello B, Fagiolini A, Vieta E, Pacchiarotti I (September 2020). «Lithium and suicide prevention in mood disorders and in the general population: A systematic review». Neuroscience and Biobehavioral Reviews. 116: 142–153. doi:10.1016/j.neubiorev.2020.06.017. PMID 32561344. S2CID 219942979.
Börjesson J, Gøtzsche PC (September 2019). «Effect of lithium on suicide and mortality in mood disorders: a systematic review». The International Journal of Risk & Safety in Medicine. 30 (3): 155–166. doi:10.3233/JRS-190058. PMID 31381531. S2CID 199451710.
Riblet NV, Shiner B, Young-Xu Y, Watts BV (November 2022). «Lithium in the prevention of suicide in adults: systematic review and meta-analysis of clinical trials». BJPsych Open. 8 (6): e199. doi:10.1192/bjo.2022.605. PMC 9707499. PMID 36384820.
Cipriani A, Hawton K, Stockton S, Geddes JR (June 2013). «Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis». BMJ. 346: f3646. doi:10.1136/bmj.f3646. PMID 23814104.
Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J (October 2006). «Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review». Bipolar Disorders. 8 (5p2): 625–639. doi:10.1111/j.1399-5618.2006.00344.x. PMID 17042835.
Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, Cummings J, van der Flier WM (April 2021). «Alzheimer's disease». Lancet. 397 (10284): 1577–1590. doi:10.1016/S0140-6736(20)32205-4. PMC 8354300. PMID 33667416.
Haussmann R, Noppes F, Brandt MD, Bauer M, Donix M (August 2021). «Lithium: A therapeutic option in Alzheimer's disease and its prodromal stages?». Neuroscience Letters. 760: 136044. doi:10.1016/j.neulet.2021.136044. PMID 34119602. S2CID 235385875.
Wei HF, Anchipolovsky S, Vera R, Liang G, Chuang DM (March 2022). «Potential mechanisms underlying lithium treatment for Alzheimer's disease and COVID-19». European Review for Medical and Pharmacological Sciences. 26 (6): 2201–2214. doi:10.26355/eurrev_202203_28369. PMC 9173589. PMID 35363371.
Hampel H, Ewers M, Bürger K, Annas P, Mörtberg A, Bogstedt A, Frölich L, Schröder J, Schönknecht P, Riepe MW, Kraft I, Gasser T, Leyhe T, Möller HJ, Kurz A, Basun H (June 2009). «Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study». The Journal of Clinical Psychiatry. 70 (6): 922–931. doi:10.4088/JCP.08m04606. PMID 19573486.
Kessing LV, Gerds TA, Knudsen NN, Jørgensen LF, Kristiansen SM, Voutchkova D, Ernstsen V, Schullehner J, Hansen B, Andersen PK, Ersbøll AK (October 2017). «Association of Lithium in Drinking Water With the Incidence of Dementia». JAMA Psychiatry. 74 (10): 1005–1010. doi:10.1001/jamapsychiatry.2017.2362. PMC 5710473. PMID 28832877.
Grandjean EM, Aubry JM (2009). «Lithium: updated human knowledge using an evidence-based approach. Part II: Clinical pharmacology and therapeutic monitoring». CNS Drugs. Springer Science and Business Media LLC. 23 (4): 331–349. doi:10.2165/00023210-200923040-00005. PMID 19374461. S2CID 38042857.
Gitlin M (December 2016). «Lithium side effects and toxicity: prevalence and management strategies». International Journal of Bipolar Disorders. 4 (1): 27. doi:10.1186/s40345-016-0068-y. PMC 5164879. PMID 27900734.
Davis J, Desmond M, Berk M (November 2018). «Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification». BMC Nephrology. Springer Science and Business Media LLC. 19 (1): 305. doi:10.1186/s12882-018-1101-4. PMC 6215627. PMID 30390660.
Yazici O, Kora K, Polat A, Saylan M (June 2004). «Controlled lithium discontinuation in bipolar patients with good response to long-term lithium prophylaxis». Journal of Affective Disorders. 80 (2–3): 269–271. doi:10.1016/S0165-0327(03)00133-2. PMID 15207941.
Gutwinski S, Fierley L, Schreiter S, Bermpohl F, Heinz A, Henssler J (October 2021). «[Lithium Withdrawal Symptoms – A Systematic Review]». Psychiatrische Praxis (գերմաներեն). Georg Thieme Verlag KG. 48 (7): 341–350. doi:10.1055/a-1481-1953. PMID 34015856. S2CID 243025798.
Aiff H, Attman PO, Aurell M, Bendz H, Ramsauer B, Schön S, Svedlund J (May 2015). «Effects of 10 to 30 years of lithium treatment on kidney function». Journal of Psychopharmacology. 29 (5): 608–614. doi:10.1177/0269881115573808. PMID 25735990. S2CID 9496408.
Baek JH, Kinrys G, Nierenberg AA (January 2014). «Lithium tremor revisited: pathophysiology and treatment». Acta Psychiatrica Scandinavica. Wiley. 129 (1): 17–23. doi:10.1111/acps.12171. PMID 23834617. S2CID 33784257.
Strawbridge R, Young AH (January 2024). «Lithium: how low can you go?». International Journal of Bipolar Disorders. 12 (1): 4. doi:10.1186/s40345-024-00325-y. PMC 10828288. PMID 38289425. «An in-depth recent study reported high interindividual variation but steeper declines in estimated glomerular filtration rate (eGFR) explained by lithium use but also found wrongful clinical attribution of some chronic kidney disease (CKD) cases to lithium (Fransson et al. 2022) which may have increased other records-based studies' estimates (Strawbridge and Young 2022). [...]»
Kessing LV (January 2024). «Why is lithium [not] the drug of choice for bipolar disorder? a controversy between science and clinical practice». International Journal of Bipolar Disorders. 12 (1): 3. doi:10.1186/s40345-023-00322-7. PMC 10792154. PMID 38228882.
Ben Salem C, Fathallah N, Hmouda H, Bouraoui K (January 2011). «Drug-induced hypoglycaemia: an update». Drug Safety. Springer Science and Business Media LLC. 34 (1): 21–45. doi:10.2165/11538290-000000000-00000. PMID 20942513. S2CID 33307427.
Wetzels JF, van Bergeijk JD, Hoitsma AJ, Huysmans FT, Koene RA (1989). «Triamterene increases lithium excretion in healthy subjects: evidence for lithium transport in the cortical collecting tubule». Nephrology, Dialysis, Transplantation. 4 (11): 939–942. doi:10.1093/ndt/4.11.939. PMID 2516883.
Bendz H, Schön S, Attman PO, Aurell M (February 2010). «Renal failure occurs in chronic lithium treatment but is uncommon». Kidney International. 77 (3): 219–224. doi:10.1038/ki.2009.433. PMID 19940841.
Lambert CG, Mazurie AJ, Lauve NR, Hurwitz NG, Young SS, Obenchain RL, Hengartner NW, Perkins DJ, Tohen M, Kerner B (May 2016). «Hypothyroidism risk compared among nine common bipolar disorder therapies in a large US cohort». Bipolar Disorders. 18 (3): 247–260. doi:10.1111/bdi.12391. PMC 5089566. PMID 27226264.
Shepard TH, Brent RL, Friedman JM, Jones KL, Miller RK, Moore CA, Polifka JE (April 2002). «Update on new developments in the study of human teratogens». Teratology. 65 (4): 153–161. doi:10.1002/tera.10032. PMID 11948561.
Yacobi S, Ornoy A (2008). «Is lithium a real teratogen? What can we conclude from the prospective versus retrospective studies? A review». The Israel Journal of Psychiatry and Related Sciences. 45 (2): 95–106. PMID 18982835.
Epstein RA, Moore KM, Bobo WV (2015). «Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges». Drug, Healthcare and Patient Safety. 7: 7–29. doi:10.2147/DHPS.S50556. PMC 4284049. PMID 25565896.
Montouris G (June 2003). «Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry». Epilepsy & Behavior. 4 (3): 310–317. doi:10.1016/S1525-5050(03)00110-0. PMID 12791334. S2CID 902424.
Weinstock L, Cohen LS, Bailey JW, Blatman R, Rosenbaum JF (2001). «Obstetrical and neonatal outcome following clonazepam use during pregnancy: a case series». Psychotherapy and Psychosomatics. 70 (3): 158–162. doi:10.1159/000056242. PMID 11340418. S2CID 25166015.
Nielsen J, Kwon TH, Christensen BM, Frøkiaer J, Nielsen S (May 2008). «Dysregulation of renal aquaporins and epithelial sodium channel in lithium-induced nephrogenic diabetes insipidus». Seminars in Nephrology. 28 (3): 227–244. doi:10.1016/j.semnephrol.2008.03.002. PMID 18519084.
Alexander MP, Farag YM, Mittal BV, Rennke HG, Singh AK (January 2008). «Lithium toxicity: a double-edged sword». Kidney International. 73 (2): 233–237. doi:10.1038/sj.ki.5002578. PMID 17943083.
Sands JM, Bichet DG (February 2006). «Nephrogenic diabetes insipidus». Annals of Internal Medicine. 144 (3): 186–194. doi:10.7326/0003-4819-144-3-200602070-00007. PMID 16461963. S2CID 6732380.
Garofeanu CG, Weir M, Rosas-Arellano MP, Henson G, Garg AX, Clark WF (April 2005). «Causes of reversible nephrogenic diabetes insipidus: a systematic review». American Journal of Kidney Diseases. 45 (4): 626–637. doi:10.1053/j.ajkd.2005.01.008. PMID 15806465.
Presne C, Fakhouri F, Noël LH, Stengel B, Even C, Kreis H, Mignon F, Grünfeld JP (August 2003). «Lithium-induced nephropathy: Rate of progression and prognostic factors». Kidney International. 64 (2): 585–592. doi:10.1046/j.1523-1755.2003.00096.x. PMID 12846754.
Davis J, Desmond M, Berk M (October 2018). «Lithium and nephrotoxicity: Unravelling the complex pathophysiological threads of the lightest metal». Nephrology. Wiley. 23 (10): 897–903. doi:10.1111/nep.13263. hdl:11343/283773. PMID 29607573. S2CID 4552345.
Finley PR, O'Brien JG, Coleman RW (February 1996). «Lithium and angiotensin-converting enzyme inhibitors: evaluation of a potential interaction». Journal of Clinical Psychopharmacology. 16 (1): 68–71. doi:10.1097/00004714-199602000-00011. PMID 8834421.
Oruch R, Elderbi MA, Khattab HA, Pryme IF, Lund A (October 2014). «Lithium: a review of pharmacology, clinical uses, and toxicity». European Journal of Pharmacology. 740 (740): 464–473. doi:10.1016/j.ejphar.2014.06.042. PMID 24991789.
Case reports: (Sandyk R, Hurwitz MD (November 1983). «Toxic irreversible encephalopathy induced by lithium carbonate and haloperidol. A report of 2 cases». South African Medical Journal = Suid-Afrikaanse Tydskrif vir Geneeskunde. 64 (22): 875–876. PMID 6415823.)(Gille M, Ghariani S, Piéret F, Delbecq J, Depré A, Saussu F, de Barsy T (May 1997). «[Acute encephalomyopathy and persistent cerebellar syndrome after lithium salt and haloperidol poisoning]». Revue Neurologique. 153 (4): 268–270. PMID 9296146.)
Emilien G, Maloteaux JM (December 1996). «Lithium neurotoxicity at low therapeutic doses Hypotheses for causes and mechanism of action following a retrospective analysis of published case reports». Acta Neurologica Belgica. 96 (4): 281–293. PMID 9008777.
Netto I, Phutane VH (2012). «Reversible lithium neurotoxicity: review of the literatur». The Primary Care Companion for CNS Disorders. 14 (1): PCC.11r01197. doi:10.4088/PCC.11r01197. PMC 3357580. PMID 22690368.
Nayak SM, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR (September 2021). «Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports». Pharmacopsychiatry. 54 (5): 240–245. doi:10.1055/a-1524-2794. PMID 34348413.
Netto I, Phutane VH (2012). «Reversible lithium neurotoxicity: review of the literatur». The Primary Care Companion for CNS Disorders. 14 (1). doi:10.4088/PCC.11r01197. PMC 3357580. PMID 22690368.
Massot O, Rousselle JC, Fillion MP, Januel D, Plantefol M, Fillion G (October 1999). «5-HT1B receptors: a novel target for lithium. Possible involvement in mood disorders». Neuropsychopharmacology. 21 (4): 530–541. doi:10.1016/S0893-133X(99)00042-1. PMID 10481837.
Scheuch K, Höltje M, Budde H, Lautenschlager M, Heinz A, Ahnert-Hilger G, Priller J (January 2010). «Lithium modulates tryptophan hydroxylase 2 gene expression and serotonin release in primary cultures of serotonergic raphe neurons». Brain Research. 1307: 14–21. doi:10.1016/j.brainres.2009.10.027. PMID 19840776. S2CID 6045269.
Einat H, Manji HK (June 2006). «Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder». Biological Psychiatry. 59 (12): 1160–1171. doi:10.1016/j.biopsych.2005.11.004. PMID 16457783. S2CID 20669215.
Gould TD, Picchini AM, Einat H, Manji HK (November 2006). «Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders». Current Drug Targets. 7 (11): 1399–1409. doi:10.2174/1389450110607011399. PMID 17100580.
Böer U, Cierny I, Krause D, Heinrich A, Lin H, Mayr G, Hiemke C, Knepel W (September 2008). «Chronic lithium salt treatment reduces CRE/CREB-directed gene transcription and reverses its upregulation by chronic psychosocial stress in transgenic reporter gene mice». Neuropsychopharmacology. 33 (10): 2407–2415. doi:10.1038/sj.npp.1301640. PMID 18046304.
Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yücel M, Gama CS, Dodd S, Dean B, Magalhães PV, Amminger P, McGorry P, Malhi GS (January 2011). «Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors». Neuroscience and Biobehavioral Reviews. 35 (3): 804–817. doi:10.1016/j.neubiorev.2010.10.001. PMID 20934453. S2CID 11421586.
York JD, Ponder JW, Majerus PW (May 1995). «Definition of a metal-dependent/Li(+)-inhibited phosphomonoesterase protein family based upon a conserved three-dimensional core structure». Proceedings of the National Academy of Sciences of the United States of America. 92 (11): 5149–5153. Bibcode:1995PNAS...92.5149Y. doi:10.1073/pnas.92.11.5149. PMC 41866. PMID 7761465.
Yenush L, Bellés JM, López-Coronado JM, Gil-Mascarell R, Serrano R, Rodríguez PL (February 2000). «A novel target of lithium therapy». FEBS Letters. 467 (2–3): 321–325. Bibcode:2000FEBSL.467..321Y. doi:10.1016/s0014-5793(00)01183-2. PMID 10675562. S2CID 43250471.
Toledano E, Ogryzko V, Danchin A, Ladant D, Mechold U (April 2012). «3'-5' phosphoadenosine phosphate is an inhibitor of PARP-1 and a potential mediator of the lithium-dependent inhibition of PARP-1 in vivo». The Biochemical Journal. 443 (2): 485–490. doi:10.1042/BJ20111057. PMC 3316155. PMID 22240080.
Ghasemi M, Sadeghipour H, Mosleh A, Sadeghipour HR, Mani AR, Dehpour AR (May 2008). «Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test». European Neuropsychopharmacology. 18 (5): 323–332. doi:10.1016/j.euroneuro.2007.07.011. PMID 17728109. S2CID 44805917.
Ghasemi M, Sadeghipour H, Poorheidari G, Dehpour AR (June 2009). «A role for nitrergic system in the antidepressant-like effects of chronic lithium treatment in the mouse forced swimming test». Behavioural Brain Research. 200 (1): 76–82. doi:10.1016/j.bbr.2008.12.032. PMID 19166880. S2CID 22656735.
Ghasemi M, Raza M, Dehpour AR (April 2010). «NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test». Journal of Psychopharmacology. 24 (4): 585–594. doi:10.1177/0269881109104845. PMID 19351802. S2CID 41634565.
Malhi GS, Tanious M, Das P, Coulston CM, Berk M (February 2013). «Potential mechanisms of action of lithium in bipolar disorder. Current understanding». CNS Drugs. 27 (2): 135–153. doi:10.1007/s40263-013-0039-0. hdl:11343/218106. PMID 23371914. S2CID 26907074.
Brunello N, Tascedda F (June 2003). «Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders». The International Journal of Neuropsychopharmacology. 6 (2): 181–189. doi:10.1017/s1461145703003419. hdl:11380/305821. PMID 12890311.
Alda M (June 2015). «Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics». Molecular Psychiatry. 20 (6): 661–670. doi:10.1038/mp.2015.4. PMC 5125816. PMID 25687772.
Einat H, Kofman O, Itkin O, Lewitan RJ, Belmaker RH (1998). «Augmentation of lithium's behavioral effect by inositol uptake inhibitors». Journal of Neural Transmission. 105 (1): 31–38. doi:10.1007/s007020050035. PMID 9588758. S2CID 6707456.
Jope RS (March 1999). «Anti-bipolar therapy: mechanism of action of lithium». Molecular Psychiatry. 4 (2): 117–128. doi:10.1038/sj.mp.4000494. PMID 10208444.
Abu-Hijleh FA, Prashar S, Joshi H, Sharma R, Frey BN, Mishra RK (February 2021). «Novel mechanism of action for the mood stabilizer lithium». Bipolar Disorders. 23 (1): 76–83. doi:10.1111/bdi.13019. PMID 33037686. S2CID 222257563.
Marmol F (December 2008). «Lithium: bipolar disorder and neurodegenerative diseases Possible cellular mechanisms of the therapeutic effects of lithium». Progress in Neuro-Psychopharmacology & Biological Psychiatry. 32 (8): 1761–1771. doi:10.1016/j.pnpbp.2008.08.012. PMID 18789369. S2CID 25861243.
Cade JF (September 1949). «Lithium salts in the treatment of psychotic excitement» (PDF). The Medical Journal of Australia. 2 (10): 349–352. doi:10.1080/j.1440-1614.1999.06241.x. PMC 2560740. PMID 18142718. Արխիվացված (PDF) օրիգինալից 25 May 2006-ին.
Fieve RR (December 1999). «Lithium therapy at the millennium: a revolutionary drug used for 50 years faces competing options and possible demise». Bipolar Disorders. 1 (2): 67–70. doi:10.1034/j.1399-5618.1999.010201.x. PMID 11252660.
Mitchell PB, Hadzi-Pavlovic D (2000). «Lithium treatment for bipolar disorder» (PDF). Bulletin of the World Health Organization. 78 (4): 515–517. PMC 2560742. PMID 10885179. Արխիվացված (PDF) օրիգինալից 25 May 2006-ին.
Wen J, Sawmiller D, Wheeldon B, Tan J (17 January 2020). «A Review for Lithium: Pharmacokinetics, Drug Design, and Toxicity». CNS & Neurological Disorders Drug Targets. 18 (10): 769–778. doi:10.2174/1871527318666191114095249. PMID 31724518. S2CID 208019043.
Forlenza OV, de Paula VJ, Machado-Vieira R, Diniz BS, Gattaz WF (May 2012). «Does lithium prevent Alzheimer's disease?». Drugs & Aging. 29 (5): 335–342. doi:10.2165/11599180-000000000-00000. PMID 22500970. S2CID 23864616.
Wilson EN, Do Carmo S, Welikovitch LA, Hall H, Aguilar LF, Foret MK, Iulita MF, Jia DT, Marks AR, Allard S, Emmerson JT, Ducatenzeiler A, Cuello AC (2020). «NP03, a Microdose Lithium Formulation, Blunts Early Amyloid Post-Plaque Neuropathology in McGill-R-Thy1-APP Alzheimer-Like Transgenic Rats». Journal of Alzheimer's Disease. 73 (2): 723–739. doi:10.3233/JAD-190862. PMID 31868669. S2CID 209448822.
Ludolph AC, Brettschneider J, Weishaupt JH (October 2012). «Amyotrophic lateral sclerosis». Current Opinion in Neurology. 25 (5): 530–535. doi:10.1097/WCO.0b013e328356d328. PMID 22918486.

ncbi.nlm.nih.gov

Poels EM, Bijma HH, Galbally M, Bergink V (December 2018). «Lithium during pregnancy and after delivery: a review». International Journal of Bipolar Disorders. 6 (1): 26. doi:10.1186/s40345-018-0135-7. PMC 6274637. PMID 30506447.
Mitchell PB, Hadzi-Pavlovic D (2000). «Lithium treatment for bipolar disorder» (PDF). Bulletin of the World Health Organization. 78 (4): 515–517. PMC 2560742. PMID 10885179. Արխիվացված է օրիգինալից (PDF) 1 April 2012-ին.
Shorter E (June 2009). «The history of lithium therapy». Bipolar Disorders. 11 (Suppl 2): 4–9. doi:10.1111/j.1399-5618.2009.00706.x. PMC 3712976. PMID 19538681.
McKnight RF, de La Motte de Broöns de Vauvert SJ, Chesney E, Amit BH, Geddes J, Cipriani A (June 2019). «Lithium for acute mania». The Cochrane Database of Systematic Reviews. 2019 (6): CD004048. doi:10.1002/14651858.CD004048.pub4. PMC 6544558. PMID 31152444.
Nabi Z, Stansfeld J, Plöderl M, Wood L, Moncrieff J (September 2022). «Effects of lithium on suicide and suicidal behaviour: a systematic review and meta-analysis of randomised trials». Epidemiology and Psychiatric Sciences. 31: e65. doi:10.1017/S204579602200049X. PMC 9533115. PMID 36111461.
Nabi Z, Stansfeld J, Plöderl M, Wood L, Moncrieff J (September 2022). «Effects of lithium on suicide and suicidal behaviour: a systematic review and meta-analysis of randomised trials». Epidemiology and Psychiatric Sciences. 31: e65. doi:10.1017/S204579602200049X. PMC 9533115. PMID 36111461.
Riblet NV, Shiner B, Young-Xu Y, Watts BV (November 2022). «Lithium in the prevention of suicide in adults: systematic review and meta-analysis of clinical trials». BJPsych Open. 8 (6): e199. doi:10.1192/bjo.2022.605. PMC 9707499. PMID 36384820.
Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, Cummings J, van der Flier WM (April 2021). «Alzheimer's disease». Lancet. 397 (10284): 1577–1590. doi:10.1016/S0140-6736(20)32205-4. PMC 8354300. PMID 33667416.
Wei HF, Anchipolovsky S, Vera R, Liang G, Chuang DM (March 2022). «Potential mechanisms underlying lithium treatment for Alzheimer's disease and COVID-19». European Review for Medical and Pharmacological Sciences. 26 (6): 2201–2214. doi:10.26355/eurrev_202203_28369. PMC 9173589. PMID 35363371.
Kessing LV, Gerds TA, Knudsen NN, Jørgensen LF, Kristiansen SM, Voutchkova D, Ernstsen V, Schullehner J, Hansen B, Andersen PK, Ersbøll AK (October 2017). «Association of Lithium in Drinking Water With the Incidence of Dementia». JAMA Psychiatry. 74 (10): 1005–1010. doi:10.1001/jamapsychiatry.2017.2362. PMC 5710473. PMID 28832877.
Gitlin M (December 2016). «Lithium side effects and toxicity: prevalence and management strategies». International Journal of Bipolar Disorders. 4 (1): 27. doi:10.1186/s40345-016-0068-y. PMC 5164879. PMID 27900734.
Davis J, Desmond M, Berk M (November 2018). «Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification». BMC Nephrology. Springer Science and Business Media LLC. 19 (1): 305. doi:10.1186/s12882-018-1101-4. PMC 6215627. PMID 30390660.
Strawbridge R, Young AH (January 2024). «Lithium: how low can you go?». International Journal of Bipolar Disorders. 12 (1): 4. doi:10.1186/s40345-024-00325-y. PMC 10828288. PMID 38289425. «An in-depth recent study reported high interindividual variation but steeper declines in estimated glomerular filtration rate (eGFR) explained by lithium use but also found wrongful clinical attribution of some chronic kidney disease (CKD) cases to lithium (Fransson et al. 2022) which may have increased other records-based studies' estimates (Strawbridge and Young 2022). [...]»
Kessing LV (January 2024). «Why is lithium [not] the drug of choice for bipolar disorder? a controversy between science and clinical practice». International Journal of Bipolar Disorders. 12 (1): 3. doi:10.1186/s40345-023-00322-7. PMC 10792154. PMID 38228882.
Lambert CG, Mazurie AJ, Lauve NR, Hurwitz NG, Young SS, Obenchain RL, Hengartner NW, Perkins DJ, Tohen M, Kerner B (May 2016). «Hypothyroidism risk compared among nine common bipolar disorder therapies in a large US cohort». Bipolar Disorders. 18 (3): 247–260. doi:10.1111/bdi.12391. PMC 5089566. PMID 27226264.
Epstein RA, Moore KM, Bobo WV (2015). «Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges». Drug, Healthcare and Patient Safety. 7: 7–29. doi:10.2147/DHPS.S50556. PMC 4284049. PMID 25565896.
Netto I, Phutane VH (2012). «Reversible lithium neurotoxicity: review of the literatur». The Primary Care Companion for CNS Disorders. 14 (1): PCC.11r01197. doi:10.4088/PCC.11r01197. PMC 3357580. PMID 22690368.
Netto I, Phutane VH (2012). «Reversible lithium neurotoxicity: review of the literatur». The Primary Care Companion for CNS Disorders. 14 (1). doi:10.4088/PCC.11r01197. PMC 3357580. PMID 22690368.
York JD, Ponder JW, Majerus PW (May 1995). «Definition of a metal-dependent/Li(+)-inhibited phosphomonoesterase protein family based upon a conserved three-dimensional core structure». Proceedings of the National Academy of Sciences of the United States of America. 92 (11): 5149–5153. Bibcode:1995PNAS...92.5149Y. doi:10.1073/pnas.92.11.5149. PMC 41866. PMID 7761465.
Toledano E, Ogryzko V, Danchin A, Ladant D, Mechold U (April 2012). «3'-5' phosphoadenosine phosphate is an inhibitor of PARP-1 and a potential mediator of the lithium-dependent inhibition of PARP-1 in vivo». The Biochemical Journal. 443 (2): 485–490. doi:10.1042/BJ20111057. PMC 3316155. PMID 22240080.
Alda M (June 2015). «Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics». Molecular Psychiatry. 20 (6): 661–670. doi:10.1038/mp.2015.4. PMC 5125816. PMID 25687772.
Cade JF (September 1949). «Lithium salts in the treatment of psychotic excitement» (PDF). The Medical Journal of Australia. 2 (10): 349–352. doi:10.1080/j.1440-1614.1999.06241.x. PMC 2560740. PMID 18142718. Արխիվացված (PDF) օրիգինալից 25 May 2006-ին.
Mitchell PB, Hadzi-Pavlovic D (2000). «Lithium treatment for bipolar disorder» (PDF). Bulletin of the World Health Organization. 78 (4): 515–517. PMC 2560742. PMID 10885179. Արխիվացված (PDF) օրիգինալից 25 May 2006-ին.

dailymed.nlm.nih.gov

«Lithobid (lithium carbonate) tablet, film coated, extended release». National Library of Medicine. Noven Therapeutics, LLC. Արխիվացված օրիգինալից 5 October 2013-ին. Վերցված է 7 October 2013-ին – via DailyMed.

npsa.nhs.uk

nrls.npsa.nhs.uk

«Safer lithium therapy». NHS National Patient Safety Agency. 1 December 2009. Արխիվացված է օրիգինալից 30 January 2010-ին.

sagepub.com

journals.sagepub.com

Undurraga J, Sim K, Tondo L, Gorodischer A, Azua E, Tay KH, Tan D, Baldessarini RJ (February 2019). «Lithium treatment for unipolar major depressive disorder: Systematic review». Journal of Psychopharmacology. 33 (2): 167–176. doi:10.1177/0269881118822161. PMID 30698058. S2CID 59411183. Արխիվացված օրիգինալից 20 February 2024-ին. Վերցված է 20 February 2024-ին.

semanticscholar.org

api.semanticscholar.org

Almeida OP, Etherton-Beer C, Kelty E, Sanfilippo F, Preen DB, Page A (27 March 2023). «Lithium dispensed for adults aged ≥ 50 years between 2012 and 2021: Analyses of a 10% sample of the Australian Pharmaceutical Benefits Scheme». The American Journal of Geriatric Psychiatry (English). 31 (9): 716–725. doi:10.1016/j.jagp.2023.03.012. ISSN 1064-7481. PMID 37080815. S2CID 257824414. Արխիվացված օրիգինալից 31 March 2023-ին. Վերցված է 31 March 2023-ին.{{cite journal}}: CS1 սպաս․ չճանաչված լեզու (link)
Bauer M, Adli M, Ricken R, Severus E, Pilhatsch M (April 2014). «Role of lithium augmentation in the management of major depressive disorder». CNS Drugs. 28 (4): 331–342. doi:10.1007/s40263-014-0152-8. PMID 24590663. S2CID 256840.
Rakofsky JJ, Lucido MJ, Dunlop BW (July 2022). «Lithium in the treatment of acute bipolar depression: A systematic review and meta-analysis». Journal of Affective Disorders. 308: 268–280. doi:10.1016/j.jad.2022.04.058. PMID 35429528. S2CID 248161621.
Cai L, Chen G, Yang H, Bai Y (July 2023). «Efficacy and safety profiles of mood stabilizers and antipsychotics for bipolar depression: a systematic review». International Clinical Psychopharmacology. 38 (4): 249–260. doi:10.1097/YIC.0000000000000449. PMID 36947416. S2CID 257665886.
Hsu CW, Tsai SY, Tseng PT, Liang CS, Vieta E, Carvalho AF, Stubbs B, Kao HY, Tu YK, Lin PY (May 2022). «Differences in the prophylactic effect of serum lithium levels on depression and mania in bipolar disorder: A dose-response meta-analysis». European Neuropsychopharmacology. 58: 20–29. doi:10.1016/j.euroneuro.2022.01.112. PMID 35158229. S2CID 246754349.
Rosenberg JM, Salzman C (November 2007). «Update: new uses for lithium and anticonvulsants». CNS Spectrums. 12 (11): 831–841. doi:10.1017/S1092852900015571. PMID 17984856. S2CID 26227696.
Undurraga J, Sim K, Tondo L, Gorodischer A, Azua E, Tay KH, Tan D, Baldessarini RJ (February 2019). «Lithium treatment for unipolar major depressive disorder: Systematic review». Journal of Psychopharmacology. 33 (2): 167–176. doi:10.1177/0269881118822161. PMID 30698058. S2CID 59411183. Արխիվացված օրիգինալից 20 February 2024-ին. Վերցված է 20 February 2024-ին.
Del Matto L, Muscas M, Murru A, Verdolini N, Anmella G, Fico G, Corponi F, Carvalho AF, Samalin L, Carpiniello B, Fagiolini A, Vieta E, Pacchiarotti I (September 2020). «Lithium and suicide prevention in mood disorders and in the general population: A systematic review». Neuroscience and Biobehavioral Reviews. 116: 142–153. doi:10.1016/j.neubiorev.2020.06.017. PMID 32561344. S2CID 219942979.
Börjesson J, Gøtzsche PC (September 2019). «Effect of lithium on suicide and mortality in mood disorders: a systematic review». The International Journal of Risk & Safety in Medicine. 30 (3): 155–166. doi:10.3233/JRS-190058. PMID 31381531. S2CID 199451710.
Haussmann R, Noppes F, Brandt MD, Bauer M, Donix M (August 2021). «Lithium: A therapeutic option in Alzheimer's disease and its prodromal stages?». Neuroscience Letters. 760: 136044. doi:10.1016/j.neulet.2021.136044. PMID 34119602. S2CID 235385875.
Grandjean EM, Aubry JM (2009). «Lithium: updated human knowledge using an evidence-based approach. Part II: Clinical pharmacology and therapeutic monitoring». CNS Drugs. Springer Science and Business Media LLC. 23 (4): 331–349. doi:10.2165/00023210-200923040-00005. PMID 19374461. S2CID 38042857.
Gutwinski S, Fierley L, Schreiter S, Bermpohl F, Heinz A, Henssler J (October 2021). «[Lithium Withdrawal Symptoms – A Systematic Review]». Psychiatrische Praxis (գերմաներեն). Georg Thieme Verlag KG. 48 (7): 341–350. doi:10.1055/a-1481-1953. PMID 34015856. S2CID 243025798.
Aiff H, Attman PO, Aurell M, Bendz H, Ramsauer B, Schön S, Svedlund J (May 2015). «Effects of 10 to 30 years of lithium treatment on kidney function». Journal of Psychopharmacology. 29 (5): 608–614. doi:10.1177/0269881115573808. PMID 25735990. S2CID 9496408.
Baek JH, Kinrys G, Nierenberg AA (January 2014). «Lithium tremor revisited: pathophysiology and treatment». Acta Psychiatrica Scandinavica. Wiley. 129 (1): 17–23. doi:10.1111/acps.12171. PMID 23834617. S2CID 33784257.
Ben Salem C, Fathallah N, Hmouda H, Bouraoui K (January 2011). «Drug-induced hypoglycaemia: an update». Drug Safety. Springer Science and Business Media LLC. 34 (1): 21–45. doi:10.2165/11538290-000000000-00000. PMID 20942513. S2CID 33307427.
Montouris G (June 2003). «Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry». Epilepsy & Behavior. 4 (3): 310–317. doi:10.1016/S1525-5050(03)00110-0. PMID 12791334. S2CID 902424.
Weinstock L, Cohen LS, Bailey JW, Blatman R, Rosenbaum JF (2001). «Obstetrical and neonatal outcome following clonazepam use during pregnancy: a case series». Psychotherapy and Psychosomatics. 70 (3): 158–162. doi:10.1159/000056242. PMID 11340418. S2CID 25166015.
Sands JM, Bichet DG (February 2006). «Nephrogenic diabetes insipidus». Annals of Internal Medicine. 144 (3): 186–194. doi:10.7326/0003-4819-144-3-200602070-00007. PMID 16461963. S2CID 6732380.
Davis J, Desmond M, Berk M (October 2018). «Lithium and nephrotoxicity: Unravelling the complex pathophysiological threads of the lightest metal». Nephrology. Wiley. 23 (10): 897–903. doi:10.1111/nep.13263. hdl:11343/283773. PMID 29607573. S2CID 4552345.
Scheuch K, Höltje M, Budde H, Lautenschlager M, Heinz A, Ahnert-Hilger G, Priller J (January 2010). «Lithium modulates tryptophan hydroxylase 2 gene expression and serotonin release in primary cultures of serotonergic raphe neurons». Brain Research. 1307: 14–21. doi:10.1016/j.brainres.2009.10.027. PMID 19840776. S2CID 6045269.
Einat H, Manji HK (June 2006). «Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder». Biological Psychiatry. 59 (12): 1160–1171. doi:10.1016/j.biopsych.2005.11.004. PMID 16457783. S2CID 20669215.
Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yücel M, Gama CS, Dodd S, Dean B, Magalhães PV, Amminger P, McGorry P, Malhi GS (January 2011). «Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors». Neuroscience and Biobehavioral Reviews. 35 (3): 804–817. doi:10.1016/j.neubiorev.2010.10.001. PMID 20934453. S2CID 11421586.
Yenush L, Bellés JM, López-Coronado JM, Gil-Mascarell R, Serrano R, Rodríguez PL (February 2000). «A novel target of lithium therapy». FEBS Letters. 467 (2–3): 321–325. Bibcode:2000FEBSL.467..321Y. doi:10.1016/s0014-5793(00)01183-2. PMID 10675562. S2CID 43250471.
Ghasemi M, Sadeghipour H, Mosleh A, Sadeghipour HR, Mani AR, Dehpour AR (May 2008). «Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test». European Neuropsychopharmacology. 18 (5): 323–332. doi:10.1016/j.euroneuro.2007.07.011. PMID 17728109. S2CID 44805917.
Ghasemi M, Sadeghipour H, Poorheidari G, Dehpour AR (June 2009). «A role for nitrergic system in the antidepressant-like effects of chronic lithium treatment in the mouse forced swimming test». Behavioural Brain Research. 200 (1): 76–82. doi:10.1016/j.bbr.2008.12.032. PMID 19166880. S2CID 22656735.
Ghasemi M, Raza M, Dehpour AR (April 2010). «NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test». Journal of Psychopharmacology. 24 (4): 585–594. doi:10.1177/0269881109104845. PMID 19351802. S2CID 41634565.
Malhi GS, Tanious M, Das P, Coulston CM, Berk M (February 2013). «Potential mechanisms of action of lithium in bipolar disorder. Current understanding». CNS Drugs. 27 (2): 135–153. doi:10.1007/s40263-013-0039-0. hdl:11343/218106. PMID 23371914. S2CID 26907074.
Einat H, Kofman O, Itkin O, Lewitan RJ, Belmaker RH (1998). «Augmentation of lithium's behavioral effect by inositol uptake inhibitors». Journal of Neural Transmission. 105 (1): 31–38. doi:10.1007/s007020050035. PMID 9588758. S2CID 6707456.
Abu-Hijleh FA, Prashar S, Joshi H, Sharma R, Frey BN, Mishra RK (February 2021). «Novel mechanism of action for the mood stabilizer lithium». Bipolar Disorders. 23 (1): 76–83. doi:10.1111/bdi.13019. PMID 33037686. S2CID 222257563.
Marmol F (December 2008). «Lithium: bipolar disorder and neurodegenerative diseases Possible cellular mechanisms of the therapeutic effects of lithium». Progress in Neuro-Psychopharmacology & Biological Psychiatry. 32 (8): 1761–1771. doi:10.1016/j.pnpbp.2008.08.012. PMID 18789369. S2CID 25861243.
Wen J, Sawmiller D, Wheeldon B, Tan J (17 January 2020). «A Review for Lithium: Pharmacokinetics, Drug Design, and Toxicity». CNS & Neurological Disorders Drug Targets. 18 (10): 769–778. doi:10.2174/1871527318666191114095249. PMID 31724518. S2CID 208019043.
Forlenza OV, de Paula VJ, Machado-Vieira R, Diniz BS, Gattaz WF (May 2012). «Does lithium prevent Alzheimer's disease?». Drugs & Aging. 29 (5): 335–342. doi:10.2165/11599180-000000000-00000. PMID 22500970. S2CID 23864616.
Wilson EN, Do Carmo S, Welikovitch LA, Hall H, Aguilar LF, Foret MK, Iulita MF, Jia DT, Marks AR, Allard S, Emmerson JT, Ducatenzeiler A, Cuello AC (2020). «NP03, a Microdose Lithium Formulation, Blunts Early Amyloid Post-Plaque Neuropathology in McGill-R-Thy1-APP Alzheimer-Like Transgenic Rats». Journal of Alzheimer's Disease. 73 (2): 723–739. doi:10.3233/JAD-190862. PMID 31868669. S2CID 209448822.

snopes.com

«Urban Legends Reference Pages: 7Up». 6 August 2004. Արխիվացված օրիգինալից 6 May 2023-ին. Վերցված է 13 November 2007-ին.

tga.gov.au

ebs.tga.gov.au

«Product Information Lithicarb (Lithium carbonate)». TGA eBusiness Services. Aspen Pharmacare Australia Pty Ltd. Արխիվացված օրիգինալից 22 March 2017-ին. Վերցված է 7 October 2013-ին.

uptodate.com

Boyer EW. «Serotonin syndrome». UpToDate. Wolters Kluwer. Արխիվացված օրիգինալից 16 December 2013-ին. Վերցված է 8 October 2013-ին.
Wijdicks EF. «Neuroleptic malignant syndrome». UpToDate. Wolters Kluwer. Արխիվացված օրիգինալից 23 October 2013-ին. Վերցված է 8 October 2013-ին.

web.archive.org

«Lithium Salts». The American Society of Health-System Pharmacists. Արխիվացված օրիգինալից 8 December 2015-ին. Վերցված է 1 December 2015-ին.
Armstrong C (15 September 2008). «ACOG Guidelines on Psychiatric Medication Use During Pregnancy and Lactation». American Family Physician. 78 (6): 772. ISSN 0002-838X. Արխիվացված օրիգինալից 27 January 2022-ին. Վերցված է 27 January 2022-ին.
Sneader W (2005). Drug discovery : a history (Rev. and updated ed.). Chichester: Wiley. էջ 63. ISBN 978-0-471-89979-2. Արխիվացված օրիգինալից 8 September 2017-ին.
«The Top 300 of 2020». ClinCalc. Արխիվացված օրիգինալից 26 March 2023-ին. Վերցված է 7 October 2022-ին.
«Lithium – Drug Usage Statistics». ClinCalc. Արխիվացված օրիգինալից 10 June 2023-ին. Վերցված է 7 October 2022-ին.
Almeida OP, Etherton-Beer C, Kelty E, Sanfilippo F, Preen DB, Page A (27 March 2023). «Lithium dispensed for adults aged ≥ 50 years between 2012 and 2021: Analyses of a 10% sample of the Australian Pharmaceutical Benefits Scheme». The American Journal of Geriatric Psychiatry (English). 31 (9): 716–725. doi:10.1016/j.jagp.2023.03.012. ISSN 1064-7481. PMID 37080815. S2CID 257824414. Արխիվացված օրիգինալից 31 March 2023-ին. Վերցված է 31 March 2023-ին.{{cite journal}}: CS1 սպաս․ չճանաչված լեզու (link)
Fieve RR (1984). «Lithium: its clinical uses and biological mechanisms of action». In Habig RL (ed.). The Brain, Biochemistry, and Behavior: Proceedings of the Sixth Arnold O. Beckman Conference in Clinical Chemistry (անգլերեն). American Association for Clinical Chemistry. էջ 170. ISBN 978-0-915274-22-2. Արխիվացված օրիգինալից 26 February 2024-ին. Վերցված է 27 May 2022-ին.
Undurraga J, Sim K, Tondo L, Gorodischer A, Azua E, Tay KH, Tan D, Baldessarini RJ (February 2019). «Lithium treatment for unipolar major depressive disorder: Systematic review». Journal of Psychopharmacology. 33 (2): 167–176. doi:10.1177/0269881118822161. PMID 30698058. S2CID 59411183. Արխիվացված օրիգինալից 20 February 2024-ին. Վերցված է 20 February 2024-ին.
Bauer M, Grof P, Muller-Oerlinghausen B (2006). Lithium in Neuropsychiatry: The Comprehensive Guide. Taylor & Francis. ISBN 978-1-84184-515-9. Արխիվացված օրիգինալից 26 February 2024-ին. Վերցված է 17 July 2021-ին.
«lithium (Rx) - Eskalith, Lithobid». Medscape. WebMD. Արխիվացված օրիգինալից 4 December 2013-ին. Վերցված է 7 October 2013-ին.
«Lithobid (lithium carbonate) tablet, film coated, extended release». National Library of Medicine. Noven Therapeutics, LLC. Արխիվացված օրիգինալից 5 October 2013-ին. Վերցված է 7 October 2013-ին – via DailyMed.
«Product Information Lithicarb (Lithium carbonate)». TGA eBusiness Services. Aspen Pharmacare Australia Pty Ltd. Արխիվացված օրիգինալից 22 March 2017-ին. Վերցված է 7 October 2013-ին.
«Safer lithium therapy». NHS National Patient Safety Agency. 1 December 2009. Արխիվացված է օրիգինալից 30 January 2010-ին.
«Lithium use while Breastfeeding». LactMed. 10 March 2015. Արխիվացված օրիգինալից 8 December 2015-ին. Վերցված է 1 December 2015-ին.
«Lithium carbonate». Արխիվացված է օրիգինալից 25 October 2016-ին. Վերցված է 25 May 2016-ին.
«Lithium». WebMD. Արխիվացված օրիգինալից 2 November 2014-ին. Վերցված է 1 November 2014-ին.
Boyer EW. «Serotonin syndrome». UpToDate. Wolters Kluwer. Արխիվացված օրիգինալից 16 December 2013-ին. Վերցված է 8 October 2013-ին.
Wijdicks EF. «Neuroleptic malignant syndrome». UpToDate. Wolters Kluwer. Արխիվացված օրիգինալից 23 October 2013-ին. Վերցված է 8 October 2013-ին.
Birch NJ (2 December 2012). Lithium and the Cell: Pharmacology and Biochemistry. Academic Press. ISBN 978-0-08-098429-2. Արխիվացված օրիգինալից 26 February 2024-ին. Վերցված է 9 October 2020-ին.
«Lithium: Discovered, Forgotten and Rediscovered». inhn.org. Արխիվացված օրիգինալից 12 March 2023-ին. Վերցված է 12 March 2023-ին.
«Obituary – Shirley Aldythea Andrews – Obituaries Australia». oa.anu.edu.au. Արխիվացված օրիգինալից 26 October 2022-ին. Վերցված է 26 October 2022-ին.
Cade JF (September 1949). «Lithium salts in the treatment of psychotic excitement» (PDF). The Medical Journal of Australia. 2 (10): 349–352. doi:10.1080/j.1440-1614.1999.06241.x. PMC 2560740. PMID 18142718. Արխիվացված (PDF) օրիգինալից 25 May 2006-ին.
Mitchell PB, Hadzi-Pavlovic D (2000). «Lithium treatment for bipolar disorder» (PDF). Bulletin of the World Health Organization. 78 (4): 515–517. PMC 2560742. PMID 10885179. Արխիվացված (PDF) օրիգինալից 25 May 2006-ին.
"7 UP: The Making of a Legend". Cadbury Schweppes: America's Beverages.
«Urban Legends Reference Pages: 7Up». 6 August 2004. Արխիվացված օրիգինալից 6 May 2023-ին. Վերցված է 13 November 2007-ին.
anonymous (13 July 1950). «ISALLY'S (ad)». Painesville Telegraph. Արխիվացված օրիգինալից 28 August 2021-ին. Վերցված է 8 September 2013-ին.
«How and when to take lithium». nhs.uk (անգլերեն). 14 August 2023. Արխիվացված օրիգինալից 26 October 2023-ին. Վերցված է 6 December 2023-ին.
«Lithium brands». Drugs.com. Արխիվացված օրիգինալից 5 April 2017-ին. Վերցված է 4 April 2017-ին.

webmd.com

«Lithium». WebMD. Արխիվացված օրիգինալից 2 November 2014-ին. Վերցված է 1 November 2014-ին.

who.int

Mitchell PB, Hadzi-Pavlovic D (2000). «Lithium treatment for bipolar disorder» (PDF). Bulletin of the World Health Organization. 78 (4): 515–517. PMC 2560742. PMID 10885179. Արխիվացված է օրիգինալից (PDF) 1 April 2012-ին.
Cade JF (September 1949). «Lithium salts in the treatment of psychotic excitement» (PDF). The Medical Journal of Australia. 2 (10): 349–352. doi:10.1080/j.1440-1614.1999.06241.x. PMC 2560740. PMID 18142718. Արխիվացված (PDF) օրիգինալից 25 May 2006-ին.
Mitchell PB, Hadzi-Pavlovic D (2000). «Lithium treatment for bipolar disorder» (PDF). Bulletin of the World Health Organization. 78 (4): 515–517. PMC 2560742. PMID 10885179. Արխիվացված (PDF) օրիգինալից 25 May 2006-ին.

worldcat.org

Armstrong C (15 September 2008). «ACOG Guidelines on Psychiatric Medication Use During Pregnancy and Lactation». American Family Physician. 78 (6): 772. ISSN 0002-838X. Արխիվացված օրիգինալից 27 January 2022-ին. Վերցված է 27 January 2022-ին.
Almeida OP, Etherton-Beer C, Kelty E, Sanfilippo F, Preen DB, Page A (27 March 2023). «Lithium dispensed for adults aged ≥ 50 years between 2012 and 2021: Analyses of a 10% sample of the Australian Pharmaceutical Benefits Scheme». The American Journal of Geriatric Psychiatry (English). 31 (9): 716–725. doi:10.1016/j.jagp.2023.03.012. ISSN 1064-7481. PMID 37080815. S2CID 257824414. Արխիվացված օրիգինալից 31 March 2023-ին. Վերցված է 31 March 2023-ին.{{cite journal}}: CS1 սպաս․ չճանաչված լեզու (link)
Malhi GS, Masson M, Bellivier F (2017). The Science and Practice of Lithium Therapy. Springer International Publishing. էջ 62. ISBN 978-3-319-45923-3. OCLC 979600268.
Malhi GS, Masson M, Bellivier F (2017). The Science and Practice of Lithium Therapy. Springer International Publishing. էջ 61. ISBN 978-3-319-45923-3. OCLC 979600268.